Evaluating a Dutch version of a headache disability questionnaire
Validity and Reliability of the Dutch Version of the Headache Disability Inventory (HDI) Questionnaire
This study is testing a Dutch version of a questionnaire to see how well it helps understand the impact of headaches on people’s daily lives and emotions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | University Ghent Academic / other |
| Locations | 2 sites (Ghent, Oost-Vlaanderen and 1 other locations) |
| Trial ID | NCT05619354 on ClinicalTrials.gov |
What this trial studies
This study aims to translate and validate the Dutch version of the Henry Ford Hospital Headache Disability Questionnaire (HDI), which assesses the emotional and functional impacts of headaches on patients. Approximately 250 patients with chronic headaches will be recruited to evaluate the questionnaire's validity and reliability through various statistical methods, including face validity and internal consistency. The HDI is designed to be applicable to all headache patients, unlike many existing questionnaires that focus solely on migraines. The study will help fill a gap in the availability of validated tools for assessing headache-related disability in Dutch-speaking populations.
Who should consider this trial
Good fit: Ideal candidates include Dutch-speaking patients diagnosed with primary or secondary headaches who have experienced at least one headache day in the past month.
Not a fit: Patients with headache types not classified by the ICHD-3 or those with severe underlying conditions or mental dysfunctions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a validated tool for better assessing headache-related disability in Dutch-speaking patients, leading to improved patient care.
How similar studies have performed: While there are existing questionnaires for headache assessment, this study is novel in its focus on validating a Dutch version of the HDI, which has not been previously established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with primary or secondary headache, diagnosed by a neurologist according to the ICHD-3 classification. * At least 1 day of headache in the previous month. * Native Dutch speaking participants Exclusion Criteria: * All other headache types not classified by the ICHD-3 as primary or secondary headache. * Secondary headache in combination with underlying pathological situations (infection, trauma, tumors, brain haemorrhages) or severe psychotic or mental dysfunctions or substance use/withdrawal symptoms.
Where this trial is running
Ghent, Oost-Vlaanderen and 1 other locations
- University Hospital Ghent — Ghent, Oost-Vlaanderen, Belgium (Recruiting)
- Universiteit Gent — Ghent, Belgium (Recruiting)
Study contacts
- Principal investigator: Barbara Cagnie, Prof. Dr. — University Ghent
- Study coordinator: Marjolein Chys
- Email: Marjolein.Chys@UGent.be
- Phone: +32 9 332 5635
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.